Nick Pizzie - 09 Jun 2026 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Reporting relationship: Chief Financial Officer
Issuer ticker: AXSM
Reported as of: 09 Jun 2026
Net transaction value: -$7,922,970
SEC form: 4
Accepted by SEC: 09 Jun 2026, 17:17:05 UTC
Prior SEC filing: 23 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Nick Pizzie

Key filing fact

Nick Pizzie filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 09 Jun 2026.

Key facts

This page summarizes Nick Pizzie's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2026, 17:17.

Change

Previous filing in this sequence was filed on 23 Apr 2026.
Current net transaction value: -$7,922,970.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001742143 Primary reporting owner

Pizzie Nick

Relationship: Chief Financial Officer
Address: C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK
Signature: /s/ Nick Pizzie
Signature date: 09 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXSM transaction

Common Stock

Options Exercise

Transaction value
Shares: +33,000
Change %: +77%
Price: $3.50^*
Shares after: 75,867
Date: 09 Jun 2026
Ownership: Direct
Footnotes: F1, F2, F5

AXSM transaction

Common Stock

Sale

Transaction value: $7,922,970
Shares: -33,000
Change %: -43%
Price: $240.09
Shares after: 42,867
Date: 09 Jun 2026
Ownership: Direct
Footnotes: F2, F3, F4, F5

AXSM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 488
Date: 09 Jun 2026
Ownership: See explanation 6 below.
Footnotes: F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AXSM transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -33,000
Change %: -31%
Price: $0.000000^*
Shares after: 72,000
Date: 09 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 33,000
Exercise price: $3.50
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

Represents an exercise of stock options which was held for over 8 years and exercised prior to the 10-year expiration date of such options.

Footnote F2

Such transaction was pursuant to a pre-approved 10b5-1 plan, which has now been completed.

Footnote F3

Represents the subsequent sale of the underlying shares of the aforementioned exercise of stock options.

Footnote F4

Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $236.46 and $242.35.

Footnote F5

Includes the prior purchase of shares of common stock pursuant to the Issuer's Employee Stock Purchase Plan.

Footnote F6

Represents additional shares indirectly beneficially owned by the reporting person as custodian for his children's UTMA accounts.